Using inducible and endothelial-cell-specific gene-deleted mice, we demonstrated that SHP2 in tumor-associated endothelial cells is activated to promote tumor growth, angiogenesis, and vascular abnormalization. The gene discussed is PTPN11; the disease is neoplasm.